Higher dose eye shot aims to stretch time between treatments for vision loss

This study is testing if switching patients with wet age-related macular degeneration (AMD) from a standard 2mg eye injection to a new, higher 8mg dose can safely allow for longer periods between treatments. It will involve 50 patients who are already receiving the standard injections but may need them too frequently. Researchers will monitor vision and eye health for 12 months to see if the higher dose helps maintain vision while allowing for fewer injections.